FDA-&-EMA-New-Drug Approvals(Mid-2020 Recap)-insert
X

Find Clinical Drug Pipeline Developments & Deals by Calidi Biotherapeutics

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
Therapeutic Area filter
    Study Phase filter
      Country filter
        News Type filter
          Company filter
            refresh

            Companies By Therapeutic Area Full Screen

            Development Status Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): CAL1 vaccinia virus

            Therapeutic Area: Oncology Product Name: SVF-CAL1

            Highest Development Status: Phase I Product Type: Large molecule

            Partner/Sponsor/Collaborator: Not Applicable

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable June 22, 2020

            Details:

            Calidi’s presentations will highlight findings from translational research on the potential use of the CAL1 vaccinia virus, as well as insights from clinical trials analyzing the potential use of Calidi’s autologous SVF delivery platform.

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Supernova 1

            Therapeutic Area: Oncology Product Name: Undisclosed

            Highest Development Status: Phase I/ Phase II Product Type: Large molecule

            Partner/Sponsor/Collaborator: Won & Partners

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Series A Financing January 21, 2020

            Details:

            Amount will be used to advance manufacturing in preparation for Calidi’s pre-IND and IND filings.